The burden of symptoms experienced by patients on dialysis is rarely mentioned in patient information sheets despite being well documented in research data. There are significant barriers to medication use in ESKD including a lack of knowledge of pharmacokinetics in dialysis and conflicting information about drug dose and safety. There is a growing body of literature on the symptom management of patients with ESKD Patients need clear information about the potential effects dialysis and non-dialysis pathways
on symptom burden and how this can change with time Standardisation of tools used to collate information about symptoms can assist in the provision of information to patients. We recommend the POS-S (Renal) tool (accessible via the kcl.ac.uk website) for assessing symptom burden. “
“Dear Colleagues: On Selleck Decitabine behalf of the Organizing Committee, we are pleased to welcome you to the 12th Asian-Pacific Congress of Nephrology, a significant venue for scientific exchange between professionals from around the globe. This year’s Congress brings together more than 80 speakers from 18 countries to deliver the latest development in the field of nephrology and to examine an array
of current problems that need to be solved to enhance the kidney health of humanity. selleck products In addition, more than 440 abstracts from 40 countries have been accepted for either oral or poster presentation. We are thrilled and honored to have our speakers Exoribonuclease and colleagues to join us at APCN2010. APCN2010 will be preceded by Asian Forum of CKD Initiative and Korea-Japan HDFForum on Friday, June 4. There will then be plenary lectures that will kick off the first, second and third days of the Congress. The Ross Bailey Lecture will take place on the
fourth day. A wide choice of Symposia and CME programs featuring various fields of basic and clinical nephrology will run throughout the Congress concurrently. We believe these scientific programs will enable participants to keep abreast of the latest research and trends in nephrology. We would like to take this opportunity to extend our sincere appreciation to all our colleagues who have advised on the organization of this year’s scientific programs. We also thank those abstract submitters selected for oral/poster presentations. Your active participation in the scientific programs for APCN2010 will be greatly acknowledged. We hope your stay in Seoul to be fully enjoyable and rewarding. With warmest regards, Sung Kyu Ha, M.D., Ph.D.